Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 21, 2021 - Issue 4
Submit an article Journal homepage
267
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

The evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review

Khalaf Kridina Department of Dermatology, Rambam Health Care Campus, Haifa, IsraelView further author information
&
A. Razzaque Ahmedb Department of Dermatology, Tufts University School of Medicine, and the Center for Blistering Diseases, USACorrespondence[email protected]
View further author information
Pages 443-454 | Received 18 Sep 2020, Accepted 08 Jan 2021, Published online: 08 Mar 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christian Ciolfi, Alvise Sernicola & Mauro Alaibac. (2022) Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability. Patient Preference and Adherence 16, pages 3035-3043.
Read now

Articles from other publishers (4)

Khalaf Kridin, Noor Mruwat, Kyle T Amber & Ralf J Ludwig. (2023) Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. British Journal of Dermatology.
Crossref
Khalaf Kridin, Noor Mruwat & Ralf J. Ludwig. (2023) Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. JAMA Dermatology 159:1, pages 56.
Crossref
Fabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini & Matteo Megna. (2022) How to decrease systemic corticosteroids in pemphigus patients under rituximab. Health Science Reports 5:4.
Crossref
Thomas Schmitt & Jens Waschke. (2021) Autoantibody-Specific Signalling in Pemphigus. Frontiers in Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.